Hemispherx (HEB) Shares Down 15% Today and Down 45% Over Last Two Weeks
More News related to HEB
- Hemispherx (HEB) Shares Breaking Out as $1 Technical Level Holds; Stock Up 23%
- Morning Movers 11/27: HEB, FAZ, QLTI Higher; ING, LYG, GNV, GAF Lower
- BUYINS.NET Issues Hemispherx Biopharma SqueezeTrigger Report; Over 26 Million Shares Shorted in 2009; Next Short Squeeze Expected Above $1.13
- The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Hemispherx Biopharma, Inc.
- Hemispherx Biopharma (HEB) Says Recently Filed Lawsuit is Without Merit
Shares of the volatile Hemispherx BioPharma (AMEX: HEB) are continuing lower today following yesterday's update on Ampligen and the resulting 8% drop in the stock. Today, Hemispherx has tumbled more than 15%.
Notably, over the last two weeks (since October 21), shares of Hemispherx have sunk by more than 45% from $1.80 to around $1.13 today. Unfortunately for the bulls, volume during this period has been, on average, pretty heavy.
Related Categories
Insiders' BlogMomentum Movers
Stocks Mentioned
+0.18Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
